This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Xiamen Innovax Biotech Co., Ltd., Xiamen University. Active years: 2025.
Company Filing History:
1 out of 23 
1 out of 165 Years Active: 2025
Title: Meifeng Nie: Innovator in Vaccine Adjuvant Technology
Introduction
Meifeng Nie is a notable inventor based in Fujian, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of vaccine adjuvants. His innovative work focuses on enhancing vaccine efficacy through advanced adjuvant formulations.
Latest Patents
Meifeng Nie holds a patent for the "Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant." This invention pertains to a zinc risedronate micro/nano adjuvant with a sustained-release function, formed by the mineralization of zinc ions and risedronic acid. The patent outlines its application as a vaccine adjuvant, along with methods for its preparation and the chemical compositions involved.
Career Highlights
Throughout his career, Meifeng Nie has worked with esteemed institutions such as Xiamen University and Xiamen Innovax Biotech Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Meifeng Nie has collaborated with notable colleagues, including Qinjian Zhao and Xiaofen Huang. These partnerships have fostered a collaborative environment that enhances the research and development of vaccine technologies.
Conclusion
Meifeng Nie's contributions to vaccine adjuvant technology exemplify the importance of innovation in the pharmaceutical field. His work not only advances scientific knowledge but also has the potential to improve public health outcomes through enhanced vaccine efficacy.